EVA3M: Assessment of Vulnerability to Carotid Stenosis by MultiModal Imaging and Cellular and Molecular Biology Analysis

Sponsor
Centre Hospitalier Universitaire Dijon (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05190510
Collaborator
(none)
20
1
10
2

Study Details

Study Description

Brief Summary

Cerebrovascular accidents (CVA) are the second leading cause of death in France, and the most frequent cause of acquired physical and mental disability. Up to 90% of strokes are ischemic, among which about 15% are due to the presence of stenosis of the carotid sinus, at the base of the extracranial internal carotid artery.

For many years, only the degree of stenosis was used to assess the risk of stroke, based on the results of original studies from the 1990s. However, the significant improvement in medical treatments since then has significantly reduced the risk of stroke, and the benefits of carotid intervention are becoming increasingly debatable.

Since the publication of the latest recommendations, the degree of stenosis alone is no longer sufficient to propose an intervention, since most of them will never lead to a neurological event. In addition to stenosis greater than 60%, for the first time, other criteria must be sought to decide on treatment. For example, so-called carotid plaque "vulnerability" criteria, defining patients "at high risk of stroke," should be sought.

Condition or Disease Intervention/Treatment Phase
  • Other: Data collection
  • Procedure: collection of the carotid plaque (surgical specimen)
  • Other: anatomopathological, histological, cellular and molecular biology examinations (metabolomics and transcriptomics) on surgical specimens

Study Design

Study Type:
Observational
Anticipated Enrollment :
20 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Assessment of Vulnerability to Carotid Stenosis by MultiModal Imaging and Cellular and Molecular Biology Analysis Pilot Study
Anticipated Study Start Date :
Feb 1, 2022
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Patient with atheromatous stenosis of the internal carotid artery

Other: Data collection
Collection of data from preoperative imaging examinations (routine examination prescribed before the operation)

Procedure: collection of the carotid plaque (surgical specimen)
collection of the carotid plaque

Other: anatomopathological, histological, cellular and molecular biology examinations (metabolomics and transcriptomics) on surgical specimens
anatomopathological, histological, cellular and molecular biology examinations (metabolomics and transcriptomics) on surgical specimens

Outcome Measures

Primary Outcome Measures

  1. rate of 18FDG tracer uptake in carotid stenosis [At baseline]

  2. Degree of instability of the plate [At baseline]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with symptomatic or asymptomatic atheromatous stenosis of the internal carotid artery, of a degree ≥ 50%, for which an operative indication is retained

  • Scheduled surgery

Exclusion Criteria:
Samples collected from patients :
  • who did not have a preoperative CT angiogram of the supra-aortic trunks

  • with contraindication to MRI

  • with contraindication to PET scan

  • with a history of cervical radiotherapy

  • with uncontrolled diabetes

  • with a previous homolateral carotid endarterectomy

  • who has already undergone angioplasty-stenting of the homolateral carotid artery

  • with a neoplasia considered active / not cured

  • Surgical procedure performed in emergency

Contacts and Locations

Locations

Site City State Country Postal Code
1 Chu Dijon Bourgogne Dijon France 21000

Sponsors and Collaborators

  • Centre Hospitalier Universitaire Dijon

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire Dijon
ClinicalTrials.gov Identifier:
NCT05190510
Other Study ID Numbers:
  • STEINMETZ 2021
First Posted:
Jan 13, 2022
Last Update Posted:
Feb 14, 2022
Last Verified:
Feb 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 14, 2022